This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Eargo, Inc.(NasdaqGS:EAR) dropped from S&P TMI Index CI
Eargo, Inc.(NasdaqGS:EAR) dropped from NASDAQ Composite Index CI
Eargo Debuts Two New Devices, Expanding Portfolio of Hearing Wellness Offerings CI
Twist Bioscience Names Adam Laponis Chief Financial Officer MT
Eargo, Inc. Announces Chief Financial Officer Changes, Effective from January 5, 2024 CI
Eargo, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Top Midday Gainers MT
Wall Street Set to Open Higher Monday as Investors Parse Earnings, Await Fed Meeting MT
Patient Square Capital, LP entered into an agreement to acquire remaining 23.8% stake in Eargo, Inc. for $13 million. CI
Eargo Expands Relationship with Best Buy, Growing In-Store Presence to over 500 Locations CI
Eargo, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Earnings Flash (EAR) EARGO Reports Q2 Revenue $8.1M MT
Eargo, Inc. Announces Chief Executive Officer Changes CI
Eargo, Inc. Announces Resignation of Christian Gormsen as President and Director CI
Eargo, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Transcript : Eargo, Inc., Q1 2023 Earnings Call, May 11, 2023
Earnings Flash (EAR) EARGO Reports Q1 Revenue $11.8M, vs. Street Est of $7.6M MT
North American Morning Briefing : Stock Futures Lower as Bank Worries Persist DJ
Transcript : Eargo, Inc., Q4 2022 Earnings Call, Mar 23, 2023
Earnings Flash (EAR) EARGO Reports Q4 Revenue $12.9M, vs. Street Est of $8.1M MT
Eargo, Inc. Auditor Raises 'Going Concern' Doubt CI
Eargo Regains Compliance With Nasdaq's Minimum Bid Price Requirement MT
Eargo to Effect 1-for-20 Reverse Stock Split MT
Hearing Wellness Pioneer Eargo Launches Eargo 7, Its Most Revolutionary Device Yet, at CES CI
Eargo Says NationsBenefits Plan Members Can Buy Eargo OTC Hearing Aids; Shares Soar After-Hours MT
Chart Eargo, Inc.
More charts
Eargo, Inc. is a medical device company. The Company is engaged in developing products to improve the quality of life of people with hearing loss. Its Eargo hearing aids are virtually invisible, rechargeable, completely in-the-canal devices indicated to compensate for mild to moderate hearing loss. Its in-the-canal devices feature quality audio, which are designed to provide up to 16 hours of battery life and feature its soft flexible medical-grade silicon tips. It is marketing various versions of hearing aids, the Eargo Max, the Eargo Neo HiFi, Eargo 5, Eargo 6 and Eargo 7. The Company markets and sells its hearing aids primarily in a direct-to-consumer format, engaging consumers through a mix of digital and traditional marketing as well as select commercial partnership, and omni-channel (including retail). Its devices are self-fitting hearing aids and are adjusted by the user to meet the user's hearing needs, without pre-programming or a hearing test from a hearing care professional.
More about the company
  1. Stock Market
  2. Equities
  3. EAR Stock
  4. News Eargo, Inc.
  5. Eargo Shares Extend Gains into Pre-Market Wednesday After FDA Approves Sale of Over-The-Counter Hearing Aids